A5046114333- Adrenal and Paraganglionic Tumors
- Hormonal Regulation and Hypertension
- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Blood Pressure and Hypertension Studies
- Immunotherapy and Immune Responses
- Pituitary Gland Disorders and Treatments
LMU Klinikum
2022-2025
Ludwig-Maximilians-Universität München
2022-2025
About 10% of patients with arterial hypertension have a positive screening test for primary aldosteronism (PA) and 50% to 70% them negative confirmatory test: the appropriate follow-up these is currently unknown. We investigated incidence PA in previous testing, after at least 2-year follow-up.
Accumulating evidence suggests that primary aldosteronism (PA) is associated with several features of the metabolic syndrome, in particular obesity, type 2 diabetes mellitus, and dyslipidemia. Whether these manifestations are primarily linked to aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism (IHA) remains unclear. The aim present study was investigate differences parameters between APA IHA patients assess impact treatment on clinical characteristics.We...
Objective: About 10% of patients with hypertension has elevated aldosterone-to-renin ratio and 50-70% them have a negative confirmatory test for primary aldosteronism (PA). However, the appropriate follow-up these is currently unknown. We investigated incidence PA in previous testing PA, comprised between 2 8 years. Design method: A total 184 previously positive screening followed by were enrolled two centres: Torino München. repeated and, if positive, test: either seated saline infusion or...